Article Text

other Versions

PDF
Original article
Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort
  1. Alvaro Alonso1,
  2. Jeffrey R Misialek1,
  3. Mohamed A Amiin1,
  4. Ron C Hoogeveen2,
  5. Lin Y Chen3,
  6. Sunil K Agarwal4,5,
  7. Laura R Loehr6,
  8. Elsayed Z Soliman7,
  9. Elizabeth Selvin4
  1. 1Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minneapolis, USA
  2. 2Department of Medicine, Baylor College of Medicine and Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA
  3. 3Division of Cardiology, University of Minnesota Medical School, Minneapolis, Minneapolis, USA
  4. 4Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
  5. 5Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
  6. 6Department of Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
  7. 7Epidemiological Cardiology Research Center (EPICARE), Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
  1. Correspondence to Dr Alvaro Alonso, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Suite 300, Minneapolis, MN 55454, USA; alonso{at}umn.edu

Abstract

Background Elevated levels of circulating liver enzymes have been associated with increased risk of cardiovascular disease. Their possible association with atrial fibrillation (AF) has received little attention.

Methods We studied 9333 men and women, aged 53–75 years, free of AF, participating in the Atherosclerosis Risk in Communities Study followed-up from 1996 to 2010. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ glutamyl transpeptidase (GGT) were measured in stored plasma samples. Incident AF was ascertained from hospitalisations and death certificates. Associations between liver enzymes and AF incidence were assessed using multivariable Cox proportional hazards models.

Results During a mean follow-up of 12 years, 1021 incident AF events were identified. Levels of AST, and to a lesser extent ALT, showed a U-shaped association with AF risk, with higher AF risk among individuals in the two extremes of the distribution in minimally adjusted models. The associations were weakened after adjustment for potential confounders. By contrast, GGT, modelled as log base 2, was linearly associated with AF risk after multivariable adjustment: a doubling of GGT levels was associated with a 20% increased risk of AF (95% CI 10% to 30%). Additional adjustment for inflammatory markers did not appreciably affect the results. Associations were not different in men and women, in whites and blacks, among never drinkers of alcohol, and among those without prevalent heart failure.

Conclusions In this community-based prospective study, higher levels of liver enzymes, mainly GGT, were associated with an increased risk of AF. The mechanisms underlying this association deserve further scrutiny.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.